KCNT2
protein-codingpotassium sodium-activated channel subfamily T member 2, the group of Potassium sodium-activated channel subfamily T |MicroRNA protein coding host genes
Gene summary
Enables chloride-activated potassium channel activity and intracellular sodium-activated potassium channel activity. Involved in potassium ion export across plasma membrane. Located in plasma membrane. Implicated in developmental and epileptic encephalopathy 57. [provided by Alliance of Genome Resources, Jul 2025]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~383.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0033366
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0100038
Submitter: ClinGen
*KCNT2* was first reported in relation to complex neurodevelopmental disorder in 2017 (Gururaj, et.al. PMID: 29069600). This condition is characterized by early-onset seizures, global developmental delays, dysmorphic features, short stature, and neurological features such as hypotonia, spasticity, and poor visual attention. Included in this curation are 17 total variants (1 small deletion and 16 missense variants). They have been reported in 22 probands in 8 publications (PMIDs: 38510274, 37062836, 29740868, 34061450, 34276763, 29069600, 32773162, 32931186). More evidence is available in the literature, but the maximum score for genetic evidence (12pts.) has been reached. The mechanism of pathogenicity is attributed to an alteration of channel electrophysiology, including some studies that suggest a gain-of-function mechanism (PMID: 29069600). There are published functional studies showing a decrease in channel activity for certain variants (PMID: 37062836) and two truncating variants have been published in the literature (PMID: 32038177), however they have not been included in this curation and haploinsufficiency as a mechanism for this disease association is unclear at this time. In summary, there is definitive evidence supporting the relationship between *KCNT2* and complex neurodevelopmental disorder. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Epilepsy GCEP on the meeting date June 16, 2026 (SOP Version 12).
Inheritance Pattern: AD
Disease ID:MONDO:0033366
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0033366
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0033366
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision making, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to KCNT2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_198503.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 40 | 46 | |||
| missense | 3 | 7 | 235 | 22 | 267 | |
| nonsense | 5 | 9 | 14 | |||
| start loss | 0 | |||||
| frameshift | 1 | 4 | 12 | 17 | ||
| splice donor/acceptor (+/-2bp) | 1 | 8 | 9 | |||
| Total | 4 | 17 | 270 | 62 | 0 | 353 |
Highest pathogenic variant AF is 0.000003460744
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_940905.2 | 28 | MANE Select | |
| Ensembl | ENSP00000294725.8 | 28 | MANE Select | |
| RefSeq | NP_001274748.1 | 27 | Standard | |
| RefSeq | NP_001274749.1 | 27 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- regulation of membrane potential
- potassium ion export across plasma membrane
Molecular Function
- intracellular sodium activated potassium channel activity
- ATP binding
- outward rectifier potassium channel activity
- chloride-activated potassium channel activity
Cellular Component
- plasma membrane
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000294725
- Coding exons
- 28
- Length
- 383447
- Individuals with no LoFs
- 125724
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 23
- Defined
- 125747
- p
- 0.0000915
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.56 | 340 | 582 | 0.585 | 0.0000282 | 7452 |
| Missense (PolyPhen) | 108 | 253.36 | 0.42627 | 3318 | ||
| Synonymous | -1.10 | 223 | 203 | 1.10 | 0.0000101 | 2093 |
| Loss of Function | 5.74 | 17 | 68.1 | 0.250 | 0.00000384 | 812 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00012 | 0.00012 | rare |
| Latino/Admixed American | 0.000058 | 0.000058 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00028 | 0.00027 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.000089 | 0.000088 | rare |
| South Asian | 0.000066 | 0.000065 | rare |
| Other | 0.00017 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Outward rectifying potassium channel. Produces rapidly activating outward rectifier K(+) currents. Activated by high intracellular sodium and chloride levels (PubMed:14684870, PubMed:16687497, PubMed:29069600). Channel activity is inhibited by ATP and by inhalation anesthetics, such as isoflurane (PubMed:16687497) (By similarity). Inhibited upon stimulation of G-protein coupled receptors, such as CHRM1 and GRM1 (PubMed:16687497). {ECO:0000250|UniProtKB:Q6UVM4, ECO:0000269|PubMed:14684870, ECO:0000269|PubMed:16687497, ECO:0000269|PubMed:29069600}.;
- Disease
- DISEASE: Epileptic encephalopathy, early infantile, 57 (EIEE57) [MIM:617771]: A form of epileptic encephalopathy, a heterogeneous group of severe childhood onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. EIEE57 is an autosomal dominant condition. {ECO:0000269|PubMed:29069600}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.144
Intolerance Scores
- RVIS EVS
- -1.29
- RVIS percentile EVS
- 5.08
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.450
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |